PAX2 and PAX8 expression in the ovarian surface epithelium and inclusion cysts

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 1100-1102

  Ozcan, Ayhan ^a   Truong, Luan D ^b,c,d  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863299876     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182500c4d     Document Type: Letter

References (5)

1. Bowen NJ, Logani S, Dickerson EB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104:331-337. (Pubitemid 46135661)
2. Li J, Abushahin N, Pang S, et al. Tubal origin of "ovarian" low-grade serous carcinoma. Mod Pathol. 2011;24:1488-1499.
3. Moretti L, Medeiros LJ, Kunkalla K, et al. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas. Mod Pathol. 2012;25:231-236.
4. Ozcan A, Liles N, Coffey D, et al. PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol. 2011;35: 1837-1847.
5. Tong GX, Chiriboga L, Hamele-Bena D, et al. Expression of PAX-2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mü llerian system origin? Mod Pathol. 2007; 20:856-863. (Pubitemid 47077268)